Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
Conditions
- Hereditary Breast and Ovarian Cancer Syndrome
- Osteoporosis
- Ovarian Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Zoledronic Acid
Sponsor
Gynecologic Oncology Group
Collaborators